___

• 1. Fleming A. On the antibacterial action of the culture of a penicillium, with special reference to their use in the isolation of B.Influenza. Br J Exp Pathol 1929;10(3):226-36. 2. Aminov R. History of antimicrobial drug discovery: major classes and health impact. Biochem Pharmacol 2017;133:4-19. 3. Goossens H, Ferech M, Stichele Vander R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365:579-87. 4. Shorr AF. Epidemiology and economic impact of methicillin-resistant Staphylococcus aureus: review and analysis of the literature. Pharmacoeconomics 2007;25:751-68. 5. Fernandes P, Martens E. Antibiotics in late clinical development. Biochem Pharmacol 2017;133:152-163. 6. Theuretzbacher U. Antibiotic innovation for future public health needs. Clin Microbiol Infect 2017;23(10):713-17. 7. Akılcı ilaç kullanımı Ulusal eylem planı 2014-2017 [internet]. Health Ministry of Turkey Republic. [cited 2019 February 10]. Avaliable from: www.akilciilac.gov.tr/wp-content/uploads/2014/11/aik-ulusal-eylem-plani.pdf. 8. Devrim İ, Gülfidan G, Tavlı V, Dizdarer C, Yaşar N, Oruç Y et al. Dr. Behçet Uz Çocuk Hastanesinde antibiyotik kullanımına ilişkin nokta prevalans çalışması. J Pediatr Inf 2009;3:11-3. 9. Ergül AB, Gokcek I, Çelik T, Torun YA. Assessment of inappropriate antibiotic use in pediatric patients: point-prevelance study. Turk Pediatri Ars 2018;53(1):17-23. 10. Chiotos K, Gerber JS, Himebauch AS. How can we optimize antibiotic use in the PICU? Pediatr Crit Care Med 2017;18(9):903-04.